
FDA Delays Full Approval Decision On Novavax's COVID-19 Vaccine (UPDATED)
Editor’s Note: The story has been updated with comments from Novavax In September 2024, the U.S. Food And Drug Administration (FDA) granted Emergency Use Authorization to Novavax Inc.'s NVAX COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) (NVX-CoV2705 …